Wilson Sonsini Goodrich & Rosati advised Vida Ventures and Temasek on the deal. Locanabio, Inc., an RNA-targeting gene therapy company focused on developing life-changing therapies for…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
